HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Rating of “Moderate Buy” from Brokerages

HealthEquity, Inc. (NASDAQ:HQY) has earned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, eleven have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $121.3077.

Several equities analysts recently issued reports on HQY shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. KeyCorp reduced their price target on HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a research report on Wednesday, October 8th. Royal Bank Of Canada upped their price objective on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 3rd. JPMorgan Chase & Co. increased their price target on HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research note on Wednesday, September 3rd. Finally, Raymond James Financial restated a “strong-buy” rating and issued a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th.

Insiders Place Their Bets

In other HealthEquity news, EVP Delano Ladd sold 6,000 shares of the company’s stock in a transaction on Friday, September 19th. The stock was sold at an average price of $94.11, for a total value of $564,660.00. Following the transaction, the executive vice president directly owned 79,456 shares of the company’s stock, valued at $7,477,604.16. This represents a 7.02% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the company’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the transaction, the executive vice president directly owned 49,795 shares in the company, valued at approximately $4,392,416.95. This represents a 3.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by corporate insiders.

Institutional Trading of HealthEquity

Large investors have recently modified their holdings of the stock. Farther Finance Advisors LLC grew its holdings in shares of HealthEquity by 232.4% during the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock worth $26,000 after purchasing an additional 172 shares in the last quarter. WPG Advisers LLC bought a new position in shares of HealthEquity during the first quarter worth about $28,000. Caitong International Asset Management Co. Ltd bought a new position in shares of HealthEquity during the second quarter worth about $33,000. Cullen Frost Bankers Inc. raised its position in shares of HealthEquity by 172.3% during the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after acquiring an additional 224 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its position in shares of HealthEquity by 176.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company’s stock worth $58,000 after acquiring an additional 418 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Performance

HealthEquity stock opened at $93.23 on Tuesday. The stock has a 50-day simple moving average of $91.66 and a 200 day simple moving average of $93.95. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity has a 12-month low of $74.07 and a 12-month high of $116.65. The stock has a market capitalization of $8.03 billion, a price-to-earnings ratio of 56.50, a P/E/G ratio of 1.30 and a beta of 0.47.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.92. The business had revenue of $325.80 million during the quarter, compared to analysts’ expectations of $320.68 million. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. On average, research analysts anticipate that HealthEquity will post 2.32 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.